Grit Zahn

2.0k total citations
47 papers, 1.7k citations indexed

About

Grit Zahn is a scholar working on Immunology and Allergy, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Grit Zahn has authored 47 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Immunology and Allergy, 18 papers in Radiology, Nuclear Medicine and Imaging and 16 papers in Molecular Biology. Recurrent topics in Grit Zahn's work include Cell Adhesion Molecules Research (24 papers), Monoclonal and Polyclonal Antibodies Research (9 papers) and Glaucoma and retinal disorders (8 papers). Grit Zahn is often cited by papers focused on Cell Adhesion Molecules Research (24 papers), Monoclonal and Polyclonal Antibodies Research (9 papers) and Glaucoma and retinal disorders (8 papers). Grit Zahn collaborates with scholars based in Germany, United States and United Kingdom. Grit Zahn's co-authors include Roland Stragies, Tina Dietrich-Ntoukas, Felix Bock, Claus Cursiefen, Björn Bachmann, Horst Kessler, Jasmine Onderka, Friedrich E. Kruse, Luciana Marinelli and Dominik Heckmann and has published in prestigious journals such as Angewandte Chemie International Edition, The Journal of Immunology and Journal of Molecular Biology.

In The Last Decade

Grit Zahn

47 papers receiving 1.7k citations

Peers

Grit Zahn
Alex O. Morla United States
Ergang Shi United States
R H Goldfarb United States
Morgan O’Hayre United States
Qian Zhan United States
Lori J. Kornberg United States
Tammy L. Moser United States
U. Hofmann Germany
Alex O. Morla United States
Grit Zahn
Citations per year, relative to Grit Zahn Grit Zahn (= 1×) peers Alex O. Morla

Countries citing papers authored by Grit Zahn

Since Specialization
Citations

This map shows the geographic impact of Grit Zahn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Grit Zahn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Grit Zahn more than expected).

Fields of papers citing papers by Grit Zahn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Grit Zahn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Grit Zahn. The network helps show where Grit Zahn may publish in the future.

Co-authorship network of co-authors of Grit Zahn

This figure shows the co-authorship network connecting the top 25 collaborators of Grit Zahn. A scholar is included among the top collaborators of Grit Zahn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Grit Zahn. Grit Zahn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jagla, Wolfgang, Konstantin Drexler, Michael P. Krahn, et al.. (2024). Expression of the plasma membrane citrate carrier (pmCiC) in human cancerous tissues—correlation with tumour aggressiveness. Frontiers in Cell and Developmental Biology. 12. 1308135–1308135. 1 indexed citations
3.
Dietrich-Ntoukas, Tina, Felix Bock, Jasmine Onderka, et al.. (2024). Selective, Temporary Postoperative Inhibition of Lymphangiogenesis by Integrin α5β1 Blockade Improves Allograft Survival in a Murine Model of High-Risk Corneal Transplantation. Journal of Clinical Medicine. 13(15). 4418–4418. 1 indexed citations
4.
Zahn, Grit, et al.. (2023). Targeting Longevity Gene SLC13A5: A Novel Approach to Prevent Age-Related Bone Fragility and Osteoporosis. Metabolites. 13(12). 1186–1186. 4 indexed citations
5.
Gill, Dipender, Loukas Zagkos, Thomas Benzing, et al.. (2023). The citrate transporter SLC13A5 as a therapeutic target for kidney disease: evidence from Mendelian randomization to inform drug development. BMC Medicine. 21(1). 504–504. 4 indexed citations
6.
Parkinson, Eric Kenneth, Jerzy Adamski, Grit Zahn, et al.. (2021). Extracellular citrate and metabolic adaptations of cancer cells. Cancer and Metastasis Reviews. 40(4). 1073–1091. 33 indexed citations
7.
Willmes, Diana M., Christine Henke, Tina Schumann, et al.. (2017). The longevity gene INDY ( I 'm N ot D ead Y et) in metabolic control: Potential as pharmacological target. Pharmacology & Therapeutics. 185. 1–11. 34 indexed citations
8.
Frank, Andreas O., Carlos Mas‐Moruno, Herbert B. Schiller, et al.. (2010). Conformational Control of Integrin‐Subtype Selectivity in isoDGR Peptide Motifs: A Biological Switch. Angewandte Chemie International Edition. 49(48). 9278–9281. 72 indexed citations
9.
Zahn, Grit, Geoffrey P. Lewis, Dörte Vossmeyer, et al.. (2010). Assessment of the Integrin α5β1 Antagonist JSM6427 in Proliferative Vitreoretinopathy Using In Vitro Assays and a Rabbit Model of Retinal Detachment. Investigative Ophthalmology & Visual Science. 51(2). 1028–1028. 31 indexed citations
10.
Dietrich-Ntoukas, Tina, Felix Bock, Don Yuen, et al.. (2009). Cutting Edge: Lymphatic Vessels, Not Blood Vessels, Primarily Mediate Immune Rejections After Transplantation. The Journal of Immunology. 184(2). 535–539. 243 indexed citations
11.
12.
Heckmann, Dominik, Burkhardt Laufer, Luciana Marinelli, et al.. (2009). Breaking the Dogma of the Metal‐Coordinating Carboxylate Group in Integrin Ligands: Introducing Hydroxamic Acids to the MIDAS To Tune Potency and Selectivity. Angewandte Chemie International Edition. 48(24). 4436–4440. 34 indexed citations
13.
Zischinsky, Gunther, et al.. (2009). SAR of N-phenyl piperidine based oral integrin α5β1 antagonists. Bioorganic & Medicinal Chemistry Letters. 20(1). 65–68. 5 indexed citations
14.
Capone, Antonio, Víctor H. González, Jeffrey S. Heier, et al.. (2008). A Phase I Open-Label Study of Single and Repeated Doses of Intravitreal JSM6427, a Small Molecule Integrin 5β1 Antagonist, in Neovascular Age-Related Macular Degeneration (AMD). Investigative Ophthalmology & Visual Science. 49(13). 1259–1259. 3 indexed citations
15.
Färber, Katrin, Michael Synowitz, Grit Zahn, et al.. (2008). An α5β1 integrin inhibitor attenuates glioma growth. Molecular and Cellular Neuroscience. 39(4). 579–585. 42 indexed citations
16.
Maier, Anna-Karina B., Norbert Kociok, Grit Zahn, et al.. (2007). Modulation of Hypoxia-Induced Neovascularization by JSM6427, an Integrin α5β 1 Inhibiting Molecule. Current Eye Research. 32(9). 801–812. 25 indexed citations
17.
Dietrich-Ntoukas, Tina, Jasmine Onderka, Felix Bock, et al.. (2007). Inhibition of Inflammatory Lymphangiogenesis by Integrin α5 Blockade. American Journal Of Pathology. 171(1). 361–372. 87 indexed citations
18.
Dietrich-Ntoukas, Tina, Jasmine Onderka, Felix Bock, et al.. (2006). Inhibition Of Inflammatory Lymphangiogenesis In The Cornea By Blocking Integrin Alpha 5. Investigative Ophthalmology & Visual Science. 47(13). 3907–3907. 1 indexed citations
19.
Umeda, Naoyasu, Shu Kachi, Hideo Akiyama, et al.. (2006). Suppression and Regression of Choroidal Neovascularization by Systemic Administration of an α5β1 Integrin Antagonist. Molecular Pharmacology. 69(6). 1820–1828. 60 indexed citations
20.
Zahn, Grit, Arne Skerra, & Wolfgang Höhne. (1999). Investigation of a tetracycline-regulated phage display system. Protein Engineering Design and Selection. 12(12). 1031–1034. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026